T. Rowe Price Investment Management, Inc. Ionis Pharmaceuticals Inc Transaction History
T. Rowe Price Investment Management, Inc.
- $151 Billion
- Q1 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 16,175,533 shares of IONS stock, worth $666 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
16,175,533
Previous 14,169,199
14.16%
Holding current value
$666 Million
Previous $495 Million
1.48%
% of portfolio
0.32%
Previous 0.31%
Shares
11 transactions
Others Institutions Holding IONS
# of Institutions
412Shares Held
147MCall Options Held
886KPut Options Held
511K-
Vanguard Group Inc Valley Forge, PA16.7MShares$688 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$509 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$425 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$347 Million0.05% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.85MShares$323 Million5.5% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.85B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...